Related Experiment Videos
[A model of mononuclear phagocyte block using carrageenan-kappa]
Patologicheskaia Fiziologiia I Eksperimental'Naia Terapiia
|January 1, 1990
Summary
Carrageenan-kappa injections in mice can induce a temporary macrophage block, impacting phagocyte function. The extent and duration of this block are dose-dependent and can be monitored via peripheral blood monocyte levels.
Area of Science:
- Immunology
- Pharmacology
Background:
- Mononuclear phagocytes are crucial for immune responses.
- Carrageenan is known to modulate immune cell activity.
Purpose of the Study:
- To investigate the effect of carrageenan-kappa on macrophage phagocytic capacity in mice.
- To establish a model for inducing and monitoring macrophage blockade.
Main Methods:
- Intraperitoneal injections of varying carrageenan-kappa doses (1.0-10 mg/mouse) in CBA mice.
- Assessment of mononuclear phagocyte ingesting capacity.
- Monitoring of peripheral blood monocyte levels.
Main Results:
- Carrageenan-kappa induced a dose-dependent macrophage block of 10- and 24-hour duration.
- Optimal doses for blockade were identified as 2.5 and 5 mg/mouse.
- Macrophage blockade was associated with monocytopenia in peripheral blood.
Conclusions:
- Carrageenan-kappa can be used to create a controllable macrophage block model in mice.
- Peripheral blood monocyte response serves as an indicator for the depth and duration of the macrophage block.